Andrew Spaventa - Mar 24, 2022 Form 4 Insider Report for Singular Genomics Systems, Inc. (OMIC)

Role
Chief Executive Officer, Director
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Stock symbol
OMIC
Transactions as of
Mar 24, 2022
Transactions value $
$0
Form type
4
Date filed
3/24/2022, 09:30 PM
Previous filing
Mar 8, 2022
Next filing
Feb 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common Stock Other -173K -100% 0 Mar 24, 2022 By Axon Holdings, LLC F1, F2
transaction OMIC Common Stock Other +9.77K 9.77K Mar 24, 2022 Direct F1, F3
holding OMIC Common Stock 4.41M Mar 24, 2022 By The Andrew K. Spaventa Living Trust dated April 9, 2014
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were distributed on a pro rata basis by Axon Holdings, LLC.
F2 The shares are held directly by Axon Holdings, LLC. The managing member of Axon Holdings, LLC is Axon Managers, LLC. The Reporting Person is a managing member of Axon Managers, LLC and may be deemed to have shared voting and investment power over the shares held by Axon Holdings, LLC. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
F3 The shares were acquired in connection with a pro rata distribution by Axon Holdings, LLC.